The Historical Review Panel that advises the Central Intelligence Agency on declassification of historical intelligence records said this week that its planned December 2018 meeting was canceled by CIA, and that no future meetings were scheduled.
But CIA said yesterday that the Panel would be reconvened following some administrative changes.
“We have recently been informed that the Panel is being restructured and will not meet again until this has been done,” said the Panel of independent historians, chaired by Prof. Robert Jervis of Columbia University, in a January 14 statement published on H-DIPLO. “The reasons for this remain unclear to us, and no schedule for resumed meetings has been announced.”
Upon further investigation, it appears that changes may be made regarding composition of Panel membership, term limits, and similar issues but that the scope of the Panel’s activities will be unaffected. The reconstituted Panel is expected to meet again sometime this year.
“The CIA is committed to the public release of historical information, and the Historical Review Panel remains an important and valuable resource for this endeavor,” said CIA spokesperson Sara Lichterman.
The Panel is purely advisory and does not make or execute policy. But it serves to represent the concerns of historians regarding declassification of intelligence records. It has helped to prioritize records of particular interest for declassification and to facilitate production of intelligence records for the Foreign Relations of the United States series. And perhaps most important, through its periodic meetings with the CIA Director, it has helped to elevate historians’ concerns about intelligence declassification within the Agency.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.
Inconsistent metrics and opaque reporting make future AI power‑demand estimates extremely uncertain, leaving grid planners in the dark and climate targets on the line